Showing results (1701-1710 of 30,483) with videos related to

Sort By:
Pageof 3,049
Frontiers in Pharmacology|August 2, 2021
Repeated Use of Prescription Drugs in Pediatrics: Comprehensive Overview Based on German Claims DataOliver Scholle, Antje Neubert, Oliver Riedel, et al.
Frontiers in Pharmacology|August 2, 2021
Corrigendum: Total Flavonoids of Rhizoma Drynariae Promotes Differentiation of Osteoblasts and Growth of Bone Graft in Induced Membrane Partly by Activating Wnt/β-Catenin Signaling PathwayShuyuan Li, Hongliang Zhou, Cheng Hu, et al.
Frontiers in Pharmacology|November 9, 2018
Berberine Attenuated Proliferation, Invasion and Migration by Targeting the AMPK/HNF4α/WNT5A Pathway in Gastric CarcinomaQian Hu, Lingli Li, Xin Zou, et al.
Frontiers in Pharmacology|November 9, 2018
Confused Connections? Targeting White Matter to Address Treatment Resistant SchizophreniaCandice E Crocker, Philip G Tibbo
Frontiers in Pharmacology|November 9, 2018
Impact of Global DNA Methylation in Treatment Outcome of Colorectal Cancer PatientsMariam A Fouad, Salem E Salem, Marwa M Hussein, et al.
Frontiers in Pharmacology|November 9, 2018
Da-Bu-Yin-Wan Improves the Ameliorative Effect of DJ-1 on Mitochondrial Dysfunction Through Augmenting the Akt Phosphorylation in a Cellular Model of Parkinson's DiseaseYi Zhang, Xiao-Gang Gong, Hong-Mei Sun, et al.
Frontiers in Pharmacology|November 9, 2018
Icariside II Ameliorates Cognitive Impairments Induced by Chronic Cerebral Hypoperfusion by Inhibiting the Amyloidogenic Pathway: Involvement of BDNF/TrkB/CREB Signaling and Up-Regulation of PPARα and PPARγ in RatsCaixia Yin, Yuanyuan Deng, Yuangui Liu, et al.
Frontiers in Pharmacology|November 10, 2018
HBK-17, a 5-HT1A Receptor Ligand With Anxiolytic-Like Activity, Preferentially Activates ß-Arrestin SignalingKarolina Pytka, Monika Głuch-Lutwin, Elżbieta Żmudzka, et al.
Frontiers in Pharmacology|October 24, 2018
Pioglitazone Represents an Effective Therapeutic Target in Preventing Oxidative/Inflammatory Cochlear Damage Induced by Noise ExposureFabiola Paciello, Anna Rita Fetoni, Rolando Rolesi, et al.
Frontiers in Pharmacology|October 26, 2018
Olmutinib (BI1482694/HM61713), a Novel Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor, Reverses ABCG2-Mediated Multidrug Resistance in Cancer CellsWei Zhang, Ying-Fang Fan, Chao-Yun Cai, et al.
Pageof 3,049